251 286 - Biotech Bayern

Recommendations

Info

multi-servicemonitoring Contact: Dr. Josef Reisinger Waffnergasse 1 D-93047 Regensburg Phone: +49 (0) 941 3782498 Fax: +49 (0) 941 6308648 josef.reisinger@multi-service-monitoring.de www.multi-service-monitoring.de Contact: Dr. Jutta Huber Anzinger Str. 7a D-85560 Ebersberg Phone: +49 (0) 8092 8289-0 Fax: +49 (0) 8092 21084 E-Mail: info@mwgdna.com Internet: www.mwg-biotech.com Contact: Dr. Niels Fertig Erzgiessereistr. 4 D-80335 München Phone: +49 (0) 89 218997972 Fax: +49 (0) 89 218997960 E-Mail: info@nanion.de Internet: www.nanion.de 88 multi-service-monitoring CRO Central European Investigator Sponsored Research Institute is an investigator sponsored research institute that specialises in monitoring clinical studies in Central Europe. With its locations in the Biopark in Regensburg and Bratislava, multi-service-monitoring integrates with networks in Germany, Austria, Switzerland, the Czech Republic, Slovakia and Hungary. All tasks are carried out in accordance with the international guidelines ICH/GCP or the appropriate national regulations. Our staff and testers undergo continuous further training and are very experienced in carrying out studies. MWG Biotech GmbH BIOTECH DNA/PROTEIN ANALYTICS Keywords: Genomics, Antisense/Nucleotides, Automation, PCR, Small Molecules MWG Biotech GmbH is an international provider of genomic services established around the core business lines DNA sequencing, oligonucleotide, siRNA and gene synthesis. The companies main mission is focussed on customer convenience and high quality services in industrial scale for the life science industries and academic research institutions around the world. Nanion Technologies GmbH BIOTECH DEVICES & REAGENTS Keywords: Devices, Nanobiotechnology Nanion Technologies is a spin-off from the Center for Nanoscience (CeNS) of the University of Munich (LMU). Nanion combines bio- and microtechnology in a company serving the life sciences industry by offering products and services which will dramatically increase the speed and efficiency of the drug discovery process in an important segment of the pharmaceutical market. Nanion bases its business on a proprietary chip technology and will design and develop High Throughput Screening (HTS) systems for ion channel active drugs (ICADs). Ion channels are prime targets for innovative medicines aimed at many important diseases.
NascaCell Technologies AG BIOTECH DEVICES & REAGENTS Keywords: Drug Development, Aptamer Technology, Peptide/Protein NascaCell Technologies AG is a global leader in the automated production and marketing of aptamers and Microbodies. Aptamers are small, functional oligonucleotides binding to target proteins with very high affinities and specificities. Because of their drug like binding characteristics, aptamers typically show strong inhibition of protein function. NascaCell selects aptamers in a rapid, automated procedure. This allows their generation in 8-10 weeks with proven track record in target validation and drug discovery. Microbodies are very small (ca 35 amino acids) and extremely stable proteins. Active peptides can be grafted or new sequences identified with bacterial display. Microbodies combine the selectivity of biologic agents with the ease of handling and storage of small molecule drug compounds. NeuroProfile GmbH BIOTECH THERAPEUTICS & DIAGNOSTICS NeuroProfile is committed to the discovery and development of novel therapeutics for the treatment of Central Nervous System (CNS) diseases. The main objective is the identification and commercialization of novel neuronal drug targets (disease-related genes or proteins) for the most important neurodegenerative diseases Alzheimer and Parkinson and for psychiatric disorders such as schizophrenia and depression. Our targets will be the basics for forthcoming drug generations with new mechanisms of action that not only ameliorate the disease symptoms, but potentially prevent or block progression of the disease. Several patent pending target candidates are run in preclinical validation projects. NIGU Chemie GmbH PHARMA & CHEMICAL INDUSTRY Nigu offers a full range of high-purity guanidine salts for biotechnological applications, which meet the supreme quality standards set by the biopharmaceutical industry. The product group includes several grades of guanidine hydrochloride for separation and purification of recombinant proteins and antibodies. Guanidine thiocyanate for nucleic acid based diagnostics is another integral part of the portfolio. A typical example is to provide guanidine-salts and recycling of used solutions as a complete package to the biopharmaceutical industry. Contact: Dr. Michael Szardenings Max-Lebsche-Platz 31 3. OG, Modul D D-81377 München Phone: +49 (0) 89 54 72 72 10 Fax: +49 (0) 89 54 72 72 22 E-Mail: customer@nascacell.de Internet: www.nascacell.de Contact: Dr. Thomas Rohrmeier Josef-Engert-Str. 9 D-93053 Regensburg Phone: +49 (0) 941 7853690 Fax: +49 (0) 941 7853699 E-Mail: info@neuroprofile.com Internet: www.neuroprofile.com Contact: Dr. Frank Fleischer Beuthener Str. 2 D-84478 Waldkraiburg Phone: +49 (0) 8638 962-0 Fax: +49 (0) 8638 962-286 E-Mail: info@nigu.de Internet: www.nigu.de 89
Page 3 and 4:
Biotechnology in Bavaria 2007 3
Page 5 and 6:
Content Welcome notes 06-07 Emilia
Page 7:
Especially biotechnology has to rel
Page 11 and 12:
The Companies in the Bavarian Biote
Page 13 and 14:
SIZE OF BIOTECH SME BY NUMBER OF EM
Page 16 and 17:
16 M&A Activities, Cooperations and
Page 18 and 19:
18 More about the Finance Climate V
Page 20 and 21:
20 Endurance and stamina: Biotech e
Page 22 and 23:
22 The BioTech Region Munich-Martin
Page 24:
24 Helmholtz Zentrum München More
Page 27 and 28:
GmbH was awarded the Bavarian Innov
Page 29 and 30:
CO2 output. This is where white bio
Page 31 and 32:
Directly opposite, one year later,
Page 33 and 34:
With new laboratory tests (in vitro
Page 35:
Central tasks are: general coaching
Page 38 and 39: Contact: Bettina von Klitzing Am Kl
Page 40 and 41: Contact: Silvia Schmidt Hanauerstr.
Page 42 and 43: Contact: Prof. Dr. Gottfried Brem T
Page 44 and 45: Contact: Derek Beggs Fraunhoferstr.
Page 46 and 47: Contact: Lydia Krybus Carl-Zeiss-Ri
Page 48 and 49: Contact: Dr. Alexander von Niecieck
Page 50 and 51: Contact: Dr. T. Polifke Eggenwatt 1
Page 52 and 53: Contact: Dr. Andrea Kofler Mühlens
Page 54 and 55: Contact: Dr. Günter Wich Zielstatt
Page 56 and 57: Contact: Dr. Bettina Kipp Grillparz
Page 58 and 59: Contact: Dr. Franz Kerek Am Klopfer
Page 60 and 61: Contact: Christiane Proll St.-Veit-
Page 62 and 63: Contact: Felix Raslag Am Klopferspi
Page 64 and 65: Contact: Thomas Kratzmüller Floria
Page 66 and 67: Contact: Dr. Albert Röder Am Neula
Page 68 and 69: Contact: Jasmin Amstadt Lessingstr.
Page 70 and 71: Contact: Kurt Martin Postfach 1351
Page 72 and 73: Contact: Simon Herzog Am Klopferspi
Page 74 and 75: Contact: Rudolf-Diesel-Str. 8A D-97
Page 76 and 77: Contact: Prof. Dr. Toni Lindl Balan
Page 78 and 79: Contact: Dr. Klaus Hellmann Geyersp
Page 80 and 81: Contact: Prof. Dr. Peter Schlieper
Page 82 and 83: Contact: Dieter Meyer Paul-Gerhardt
Page 84 and 85: Contact: Prof. Dr. Dr. Torsten Hafe
Page 86 and 87: Contact: Dr. Lukas Pfister Lindenpl
Page 90 and 91: Contact: Dr. Klaus-Peter Stengele B
Page 92 and 93: Contact: Michael Almstetter Am Klop
Page 94 and 95: Contact: Dr. Frank Hensel Friedrich
Page 96 and 97: Contact: Rita Fischer Lise-Meitner-
Page 98 and 99: Contact: Dr. Christian Philipp Erns
Page 100 and 101: Contact: Stefan Schöffel Mühlweg
Page 102 and 103: Contact: Dr. Ortwin Faff Carl-von-L
Page 104 and 105: Contact: Dr. Brigitte Hanke Freisin
Page 106 and 107: Contact: Prof. Dr. Peter Buckel Am
Page 108 and 109: Contact: Marcus Irsfeld Fraunhofers
Page 110 and 111: Contact: Martina Frauscher Emmy-Noe
Page 112 and 113: Contact: Rachela Mohr Hanns-Seidel-
Page 114 and 115: 114
show all

251 286 - Biotech Bayern

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?